Xiaowu Xu

Department of Pancreatic Surgery

H指数:26

被引数:2,433

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Low-dose Simvastatin protects pancreatic cancer cells by promoting mitochondrial autophagy through TFEB

Cellular Oncology

IF4.8

2026-01-190

OAAI

Tumor-derived apolipoprotein E confers resistance to temozolomide in pancreatic neuroendocrine tumors

肿瘤来源的载脂蛋白E赋予胰腺神经内分泌肿瘤对替莫唑胺的抵抗性

Cell Death & Disease

IF9.6

2025-12-130

OAAI

Mapping of Lymph Node Metastasis in Nonfunctional Pancreatic Neuroendocrine Tumors: A retrospective analysis of 455 patients

非功能性胰腺神经内分泌肿瘤淋巴结转移图谱：455例患者的回顾性分析

Pancreatology

IF2.7

2025-11-060

PRE

Case Report: Endoscopic submucosal dissection and endoscopic transcecal appendectomy for synchronous sigmoid and appendiceal adenomas with calcified Schistosoma eggs

病例报告：内镜黏膜下剥离术和经内镜经结肠盲肠切除术治疗同步性乙状结肠和阑尾腺瘤伴钙化血吸虫卵

Frontiers in Oncology

IF3.3

2025-10-010

OAAI

Liquid-Liquid Phase Separation in Major Hallmarks of Cancer

液体-液体相分离在癌症主要特征中的作用

CELL PROLIFERATION

IF5.6

2025-09-010

OAAI

NCOA6 knockdown enhances RSL3-induced ferroptosis in pancreatic cancer cells and increases the sensitivity to gemcitabine

NCOA6敲低增强RSL3诱导的胰腺癌细胞铁死亡并增加其对吉西他滨的敏感性

ACTA BIOCHIMICA ET BIOPHYSICA SINICA

IF3.4

2025-08-011

PRE

Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity in pancreatic ductal adenocarcinoma

酰基辅酶A硫酯酶8通过调节脂质代谢和抗铁死亡活性，诱导胰腺导管腺癌对吉西他滨的耐药性。

ACTA PHARMACOLOGICA SINICA

IF8.4

2025-02-120

Distinctive grade based on Ki67 index and immune microenvironment of metastatic pancreatic neuroendocrine tumors responding to capecitabine plus temozolomide

基于Ki67指数和免疫微环境的转移性胰腺神经内分泌肿瘤对卡培他滨联合替莫唑胺的特异性分级

BMC CANCER

IF3.4

2024-11-071

OAAI

IL15RA-STAT3-GPX4/ACSL3 signaling leads to ferroptosis resistance in pancreatic cancer

IL15RA-STAT3-GPX4/ACSL3信号通路导致胰腺癌对 ferroptosis 的抵抗

ACTA BIOCHIMICA ET BIOPHYSICA SINICA

IF3.4

2024-10-122

YBX1 as a therapeutic target to suppress the LRP1-(β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer

YBX1作为抑制LRP1-(β-catenin-RRM1轴并克服胰腺癌吉西他滨耐药性的治疗靶标

CANCER LETTERS

IF10.1

2024-10-011

OAAI

Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor

HUMAN CELL

IF3.1

2024-07-300

PRE

MEN1 Deficiency-Driven Activation of the β-Catenin-MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide Resistance

ADVANCED SCIENCE

IF14.1

2024-07-230

OAAI

Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via transcriptional regulation of BCAT1

CELL PROLIFERATION

IF5.6

2024-06-270

OAAI

Cancer immunometabolism: advent, challenges, and perspective

癌症免疫代谢: 来临，挑战和前景

MOLECULAR CANCER

IF33.9

2024-04-057

OAAI

Modified laparoscopic Blumgart pancreaticojejunostomy using pedicled teres ligament to reinforce the posterior wall and isolate the stump of the gastroduodenal artery

ASIAN JOURNAL OF SURGERY

IF3.8

2024-01-011

OAAI

NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3-IFIT3 axis

MOLECULAR CARCINOGENESIS

IF3.2

2023-10-171

PRE

Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment

CANCER BIOLOGY & MEDICINE

IF8.4

2023-09-281

OAAI

PITX2 in pancreatic stellate cells promotes EMT in pancreatic cancer cells via the Wnt/β-catenin pathway

胰腺星状细胞中PITX2通过Wnt/β-catenin通路促进胰腺癌细胞EMT的研究

ACTA BIOCHIMICA ET BIOPHYSICA SINICA

IF3.4

2023-06-194

OAAI

Lactate-induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer

乳酸诱导的蛋白质乳糖化: 表观遗传学与癌症代谢重编程之间的桥梁

CELL PROLIFERATION

IF5.6

2023-04-1453

OAAI

A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer

ACTA PHARMACOLOGICA SINICA

IF8.4

2023-04-036

OAAI

Xiaowu Xu

个人简介

教育背景

工作经历

荣誉奖项

研究方向